PMC2879224_01
(a) Fibroblastic rheumatism before treatment. (b) Improvement after 22 weeks, showing visible reduction of all lesions.
DRP2009-715729.001.jpg
PMC2879224_01_DRP2009-715729.001.jpg
fig1
After 22 weeks of maintenance treatment, skin fibrosis decreased and was accompanied by moderate improvement of joint mobility (Figures 1(a) and 1(b)).